Intravenous Promethazine Versus Diazepam for Treatment of Peripheral Vertigo
Phase 2
- Conditions
- Vertigo.Diseases of the ear and mastoid process
- Registration Number
- IRCT2015060122522N1
- Lead Sponsor
- Mazandaran University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Aged 18 - 65 years; Complaining of Vertigo ; There is not contraindication for intravenous promethazine and diazepam
Exclusion criteria: Patient with centeral vertigo; Traumatic Brain Injury; Pregnant; Unable to provide informed consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Control Of Symptoms. Timepoint: 30 minutes, 2 and 4 hours. Method of measurement: VAS.
- Secondary Outcome Measures
Name Time Method